---
title: "ONC SEC Filings and Financial Statements | Tradytics"
description: "Annual income statements, balance sheets and cash flows for BeOne Medicines (ONC), with links to the SEC filings."
url: "https://tradytics.com/research/ONC/fundamentals"
image: "https://tradytics.com/api/v2/og/research.png?id=ONC&v=stock-11994873"
---

# ONC financial statements and SEC filings

## ONC annual income statement

| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $5.34B | $447.14M | $286.93M | [10-K](https://www.sec.gov/Archives/edgar/data/1651308/000162828026011946/0001628280-26-011946-index.htm) |
| 2024-12-31 | $3.81B | -$568.20M | -$644.79M | [10-K](https://www.sec.gov/Archives/edgar/data/1651308/000162828026011946/0001628280-26-011946-index.htm) |
| 2023-12-31 | $2.46B | -$1.21B | -$881.71M | [10-K](https://www.sec.gov/Archives/edgar/data/1651308/000162828026011946/0001628280-26-011946-index.htm) |
| 2022-12-31 | $1.42B | -$1.79B | -$2.00B | [10-K](https://www.sec.gov/Archives/edgar/data/1651308/000165130825000031/0001651308-25-000031-index.htm) |
| 2021-12-31 | $1.18B | -$1.44B | -$1.46B | [10-K](https://www.sec.gov/Archives/edgar/data/1651308/000165130824000014/0001651308-24-000014-index.htm) |
| 2020-12-31 | $308.87M | -$1.66B | -$1.62B | [10-K](https://www.sec.gov/Archives/edgar/data/1651308/000165130823000036/0001651308-23-000036-index.htm) |

## ONC annual balance sheet

| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $8.19B | $3.83B | $4.36B | [10-Q](https://www.sec.gov/Archives/edgar/data/1651308/000162828026070477/0001628280-26-070477-index.htm) |
| 2024-12-31 | $5.92B | $2.59B | $3.33B | [10-K](https://www.sec.gov/Archives/edgar/data/1651308/000162828026011946/0001628280-26-011946-index.htm) |
| 2023-12-31 | $5.81B | $2.27B | $3.54B | [10-K](https://www.sec.gov/Archives/edgar/data/1651308/000165130825000031/0001651308-25-000031-index.htm) |
| 2022-12-31 | $6.38B | $2.00B | $4.38B | [10-K](https://www.sec.gov/Archives/edgar/data/1651308/000165130824000014/0001651308-24-000014-index.htm) |
| 2021-12-31 | $8.54B | $2.40B | $6.13B | [10-K](https://www.sec.gov/Archives/edgar/data/1651308/000165130823000036/0001651308-23-000036-index.htm) |
| 2020-12-31 | $5.60B | $1.73B | $3.87B | [10-K](https://www.sec.gov/Archives/edgar/data/1651308/000165130822000032/0001651308-22-000032-index.htm) |

## ONC annual cash flow

| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $1.13B | -$185.84M | $1.06B | [10-K](https://www.sec.gov/Archives/edgar/data/1651308/000162828026011946/0001628280-26-011946-index.htm) |
| 2024-12-31 | -$140.63M | -$492.66M | $193.45M | [10-K](https://www.sec.gov/Archives/edgar/data/1651308/000162828026011946/0001628280-26-011946-index.htm) |
| 2023-12-31 | -$1.16B | -$561.90M | $416.48M | [10-K](https://www.sec.gov/Archives/edgar/data/1651308/000162828026011946/0001628280-26-011946-index.htm) |
| 2022-12-31 | -$1.50B | -$325.43M | -$18.97M | [10-K](https://www.sec.gov/Archives/edgar/data/1651308/000165130825000031/0001651308-25-000031-index.htm) |
| 2021-12-31 | -$1.30B | -$262.94M | $3.64B | [10-K](https://www.sec.gov/Archives/edgar/data/1651308/000165130824000014/0001651308-24-000014-index.htm) |
| 2020-12-31 | -$1.28B | -$117.51M | $5.20B | [10-K](https://www.sec.gov/Archives/edgar/data/1651308/000165130823000036/0001651308-23-000036-index.htm) |

- [ONC stock research](https://tradytics.com/research/ONC)
- [ONC financial summary](https://tradytics.com/research/ONC/financials)
- [Read the data without JavaScript](https://tradytics.com/research/ONC/fundamentals?snapshot=1)
